Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.

[1]  P. Keane,et al.  Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[2]  U Chakravarthy,et al.  Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.

[3]  W. Freeman,et al.  Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts. , 2008, Ophthalmology.

[4]  D. Browning,et al.  The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. , 2008, American journal of ophthalmology.

[5]  U. Schmidt-Erfurth,et al.  Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography , 2007, British Journal of Ophthalmology.

[6]  Peter K Kaiser,et al.  Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.

[7]  C. Regillo,et al.  Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. , 2007, American journal of ophthalmology.

[8]  Paul G. Updike,et al.  Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[9]  R. Spaide.  Ranibizumab according to need: a treatment for age-related macular degeneration. , 2007, American journal of ophthalmology.

[10]  Jennifer I. Lim,et al.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.

[11]  T. Wong,et al.  Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study. , 2007, American journal of ophthalmology.

[12]  A. Augustin,et al.  TRIPLE THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION: Verteporfin PDT, Bevacizumab, and Dexamethasone , 2007, Retina.

[13]  Ziqiang Wu,et al.  Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. , 2007, Investigative ophthalmology & visual science.

[14]  P. Griffiths,et al.  SHORT-TERM EFFECTS OF FOCAL ARGON LASER TREATMENT IN DIABETIC MACULOPATHY AS DEMONSTRATED BY OPTICAL COHERENCE TOMOGRAPHY , 2007, Retina.

[15]  William J Feuer,et al.  An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.

[16]  K. Eng,et al.  Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.

[17]  U. Schmidt-Erfurth,et al.  Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment , 2006, British Journal of Ophthalmology.

[18]  Richard F Spaide,et al.  INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION , 2006, Retina.

[19]  J. Sunness.  Choroidal neovascularisation and atrophy , 2006, British Journal of Ophthalmology.

[20]  M. Killingsworth,et al.  Development of atrophy of the retinal pigment epithelium around disciform scars , 2006, British Journal of Ophthalmology.

[21]  R. Avery,et al.  Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. , 2006, Ophthalmology.

[22]  L. Labree,et al.  Errors in retinal thickness measurements obtained by optical coherence tomography. , 2006, Ophthalmology.

[23]  S. Sivaprasad,et al.  Changing from Snellen to LogMAR: debate or delay? , 2006, Clinical & experimental ophthalmology.

[24]  Peter K Kaiser,et al.  Optical coherence tomographic patterns of diabetic macular edema. , 2006, American journal of ophthalmology.

[25]  Stephen J. Aldington,et al.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study , 2005, British Journal of Ophthalmology.

[26]  W. Brannath,et al.  Optical coherence tomography guided retreatment of photodynamic therapy , 2005, British Journal of Ophthalmology.

[27]  R. Costa,et al.  Evaluation of image artifact produced by optical coherence tomography of retinal pathology. , 2005, American journal of ophthalmology.

[28]  Miguel J Maldonado,et al.  Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. , 2005, American journal of ophthalmology.

[29]  S. Harding,et al.  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study , 2005, British Journal of Ophthalmology.

[30]  Peter Wiedemann,et al.  Pathomechanisms of Cystoid Macular Edema , 2004, Ophthalmic Research.

[31]  C. Puliafito,et al.  Clinical applications of optical coherence tomography for the diagnosis and management of macular diseases. , 2004, Ophthalmology clinics of North America.

[32]  Irene Barbazetto,et al.  Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. , 2003, Archives of ophthalmology.

[33]  Christoph Kniestedt,et al.  Visual acuity and its measurement. , 2003, Ophthalmology clinics of North America.

[34]  T. Cox,et al.  Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. , 2002, Archives of ophthalmology.

[35]  K. Bartz-Schmidt,et al.  Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation , 2000, The British journal of ophthalmology.

[36]  J S Sunness,et al.  The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. , 1999, Ophthalmology.

[37]  M G Maguire,et al.  Occult choroidal neovascularization in age-related macular degeneration. A natural history study. , 1997, Archives of ophthalmology.

[38]  G Soubrane,et al.  Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment. , 1990, Ophthalmology.

[39]  R P Murphy,et al.  Natural course of poorly defined choroidal neovascularization associated with macular degeneration. , 1988, Archives of ophthalmology.

[40]  P. Liao,et al.  Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment , 1987, The Yale Journal of Biology and Medicine.